1. RAPORT BIEŻĄCY
2. MESSAGE (ENGLISH VERSION)
3. INFORMACJE O PODMIOCIE
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
KOMISJA NADZORU FINANSOWEGO | ||||||||||||
Raport bieżący nr | 5 | / | 2023 | |||||||||
Data sporządzenia: | 2023-05-09 | |||||||||||
Skrócona nazwa emitenta | ||||||||||||
MILESTONE MEDICAL | ||||||||||||
Temat | ||||||||||||
Commencing sales of CompuFlo Epidural disposables within the Sports and Spine Clinic in Oregon | ||||||||||||
Podstawa prawna | ||||||||||||
Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
Treść raportu: | ||||||||||||
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that it has commenced sales of CompuFlo® Epidural disposables into The Sports and Spine Center in Tualatin, Oregon, USA. Adoption of the technology by this clinic follows a successful evaluation process by its founder, Dr. Jimmy Huebert, MD, an interventional pain and sports medicine physician, board certified by the American College of Internal Medicine. Dr. Huebert initially conducted seven cases using the CompuFlo Epidural system, in which he reported 100% success. He has an additional 13 cases scheduled over the next 3 weeks. The evaluation included Epidural Steroid Injection (ESI) procedures in the lumbar, thoracic and cervical thoracic junctions in the spine. Epidural steroid injection (ESI) is a minimally invasive procedure that can help relieve neck, arm, back, and leg pain caused by inflamed spinal nerves due to spinal stenosis or disc herniation. Dr. Huebert has 20 plus years of experience in Sports Medicine. He specializes in non-surgical orthopedic, spine, sports and other painful injuries and conditions utilizing a variety of therapies including traditional and regenerative medicine. Dr. Huebert has practiced in the Portland area since 2001 and has served as a team physician for a variety of sports and area teams including the Portland Timbers, Portland Beavers, the Portland Marathon, area high schools and the Professional Rodeo Cowboys Association (PRCA). The Board of Directors of the Company is pleased to announce the adoption of our CompuFlo Epidural System by another pain management clinic, following successful evaluation. Based on the growing recognition of our technology among leading pain management specialists, the Board of Directors of the Company believes that the CompuFlo Epidural system will, in time, become the standard of care in epidural analgesia, especially in the thoracic cervical regions of the spine, where the incidence rates of morbidity are believed to be much higher. |
MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE>>>
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
2023-05-09 | Keisha Harcum | Controller | Keisha Harcum |